FAP and neoplasm: Recently, radiotracers targeting fibroblast activation protein (FAP) have been developed on account of the FAP-specific inhibitor (FAPI), demonstrating excellent diagnostic performance and offering a novel form of pan-tumor tracing across various cancers (20).